Director Global Market Access & Pricing, frexalimab

The stakes for this role are high. In a highly competitive MS landscape, frexalimab's ambition to redefine the standard of care demands novel approaches and best-in-class methodologies to unlock its full pricing and access potential in RMS and nrSPMS. Critically, while this role focuses on MS, the strategic choices made now in MS will set the tone and trajectory for potential follow-on indications, amplifying the long-term impact of this role well beyond the initial launch.

This is a highly collaborative role, requiring strong cross-functional partnership with Commercial, Medical, Clinical, Evidence for Access, Global Pricing, Biostatistics, Regulatory Affairs, Public Affairs teams, as well as country teams. You'll be part of a high-performing team that values strategic thinking and an unwavering focus on patient access. This position sits within the Global Market Access & Pricing Neurology Team, which is part of the Specialty Care Global Market Access organization, where collaboration, patient-centricity, and scientific rigor drive everything we do.

Main Responsibilities

• Drive development of key pricing & market access deliverables, including the market access plan, payer value story, global pricing policy informed by pricing research and other data points, contracting strategy, country launch sequencing, negotiation guide, and objection handler
• Play a key role in shaping the MS ecosystem in collaboration with Commercial, Medical, Public Affairs, other global business partners and countries to drive payer value recognition of frexalimab by the time of launch, aiming for sustainable access to innovation
• Generate actionable payer insights through primary research, payer advisory boards, or other platforms to continuously pressure test and refine frexalimab's value proposition and ensure pricing and access strategies are grounded in robust market understanding across markets
• Contribute to the development of frexalimab’s pricing and access MS strategy and scenario planning, in partnership with the Global Brand / Global Project Teams and countries, taking a holistic approach to optimize brand value
• Champion the adoption of digital and AI-enabled tools within the payer access strategy and execution for frexalimab, partnering with relevant internal stakeholders to identify opportunities that enhance payer engagement, value messaging, and decision-making support
• Ensure relevant input and engagement from countries, partnering closely with country Market Access leads to co-develop global deliverables optimally and on time to support local payer negotiations
• Work with Evidence for Access, Medical, and relevant functions to secure evidence generation plans, prioritization, and deliverables that robustly support access and pricing objectives
• Maintain deep knowledge of the MS and payer ecosystems – scientific/clinical developments, competitive landscape, payer dynamics, and healthcare policy changes – to proactively identify market access opportunities and threats and inform frexalimab’s market access and pricing strategy.

About You

• Bachelors degree minimum, advanced degree preferred
• Minimum 7 years of pharmaceutical/biotech industry experience, with an accomplished track record in pricing and market access, preferably in multiple sclerosis, neurology, or similar complex therapeutic areas
• Experience working across different payer archetypes, with deep knowledge of the US market and healthcare system
• Innovative mindset with ability to develop creative solutions to complex problems
• Proven track record of developing and executing payer shaping initiatives in challenging reimbursement environments
• Strong analytical skills, including pricing expertise, with ability to translate clinical information and messages into clear payer access strategies and recommendations
• Flexibility and demonstrated ability to work across multiple projects and priorities
• Demonstrated relationship building at all levels of the organization and across geographies; experience working collaboratively and cross-functionally
• Outstanding written and oral communication skills, with the ability to deliver clear and concise messages based on complex information
• Strong business acumen, analytical and financial skills to evaluate investment strategies; comfortable with product forecast and P&L
• Fluent in English, both written and oral